Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-16 Sale |
2025-01-17 7:21 pm |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
4,514 | $0.58 | $2,618 | 1,153,763 (Direct) |
View |
| 2024-09-12 Sale |
2024-09-13 5:08 pm |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
50,423 | $1.76 | $88,744 | 616,577 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:34 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
25,000 | $0 | 74,000 (Direct) |
View |
| 2025-01-15 Exercise |
2025-01-17 7:21 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
11,062 | $0 | 1,153,763 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-17 7:21 pm |
N/A 2035-01-14 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
997,700 | $0 | 1,153,763 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 5:08 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
166,750 | $0 | 616,577 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
17,000 | $0 | 49,000 (Direct) |
View |
| 2024-01-15 Option Award |
2024-01-17 5:19 pm |
N/A 2034-01-14 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
243,375 | $0 | 243,375 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-04 4:31 pm |
N/A 2033-10-01 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
9,102 | $0 | 9,102 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-13 4:01 pm |
N/A 2033-09-10 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. President, CEO |
1,667,000 | $0 | 1,667,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:30 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
136,500 | $0 | 136,500 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-06 4:23 pm |
N/A 2033-07-02 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
4,477 | $0 | 4,477 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:16 pm |
N/A 2033-06-07 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
32,822 | $0 | 32,822 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:15 pm |
N/A 2033-04-02 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
3,375 | $0 | 3,375 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:56 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
16,000 | $0 | 32,000 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 4:11 pm |
N/A 2032-12-31 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
136,500 | $0 | 136,500 (Direct) |
View |
| 2022-06-15 Option Award(A) |
2022-06-23 7:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:31 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:18 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:30 pm |
N/A 2032-02-21 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT OF R&D AND CMO |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:28 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:05 pm |
N/A 2032-01-02 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
10,185 | $0 | 10,185 (Direct) |
View |
| 2021-10-21 Option Award |
2021-10-25 5:17 pm |
N/A 2031-10-20 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. President of R&D and CMO |
157,058 | $0 | 157,058 (Direct) |
View |
Ownership |
2021-10-21 8:40 pm |
N/A 2030-07-22 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. President of R&D and CMO |
0 | $0 | 291,855 (Direct) |
View |
| 2021-09-15 Option Award |
2021-09-17 4:32 pm |
N/A 2031-09-15 |
Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director |
35,000 | $19.36 | 35,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 6:01 pm |
N/A 2031-06-10 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
25,050 | $0 | 25,050 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 7:02 pm |
N/A 2031-01-15 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
2,490 | $0 | 2,490 (Direct) |
View |